HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Radiology & Imaging
Meta-analysis
EBUS-TBNB yields higher diagnostic rates for lymphoma and sarcoidosis compared to EBUS-TBNA
Core Biopsy Shows Higher Yield for Lymphoma and Sarcoidosis
This meta-analysis of 1434 patients with mediastinal disorders found that EBUS-TBNB provides a significantly higher diagnostic yield for lym…
A core biopsy technique may provide more accurate results than standard needle aspiration for certain conditions like lymphoma and sarcoidos…
Jun 13, 2026
Allergy & Immunology
Meta-analysis
Immune checkpoint inhibitors appear safe in cancer patients with pre-existing sarcoidosis
Most cancer patients with sarcoidosis stay safe on immune checkpoint inhibitor therapy
A meta-analysis examined immune checkpoint inhibitor use in cancer patients with documented pre-existing sarcoidosis. Most patients showed n…
A look at 43 patients shows most do not have a flare when taking immune checkpoint inhibitors, though some do experience a flare.
Jun 1, 2026
Oncology
Meta-analysis
Network meta-analysis compares EBUS techniques for mediastinal lymphadenopathy diagnostic yield
Doctors find a better way to sample swollen lymph nodes safely
This systematic review and network meta-analysis evaluated diagnostic yield across EBUS techniques in 2357 patients with mediastinal and/or …
A new freezing biopsy technique finds the cause of swollen chest nodes more often than standard needles while staying safe for patients.
Apr 28, 2026
Allergy & Immunology
Meta-analysis
Network meta-analysis compares endoscopic techniques for sarcoidosis diagnosis
A Better Way to Diagnose Sarcoidosis Could Save Patients Months of Uncertainty
A network meta-analysis of 35 studies in patients with suspected sarcoidosis compared endoscopic tissue sampling techniques.
Getting the right diagnosis for a complex lung condition just got clearer, potentially saving patients from repeated, less effective tests.
Apr 12, 2026